Literature DB >> 8598994

MR of the pituitary in patients with Prader-Willi syndrome: size determination and imaging findings.

L Miller1, M Angulo, D Price, S Taneja.   

Abstract

Prader-Willi syndrome (PWS) is an unusual genetic disorder characterized by short stature, obesity, hypogonadism, hypotonia, cognitive impairment, and dysmorphic facies. There is an interstitial deletion of the proximal long arm of chromosome 15 in about 70 % of patients. Some of these clinical features suggest a central hypothalamic/pituitary dysfunction, and recent investigations have demonstrated a marked impairment in spontaneous growth hormone (GH) secretion. We studied 15 GH-deficient PWS patients by magnetic resonance imaging (MRI) to determine whether there was a diminution in the gross morphological size of the anterior pituitary gland, the site of GH synthesis. We also set out to catalog the pertinent imaging findings in this patient population. Our results indicate that this is the first report documenting pituitary size by MRI in PWS patients. No statistically significant difference was found in the height of the anterior pituitary gland in PWS patients compared with either normal children or children with isolated GH deficiency. An interesting imaging finding is that three of 15 patients (20 %) demonstrated complete absence of the posterior pituitary bright spot (PPBS), and a fourth patient demonstrated a small PPBS. These observations reflect an objective physiologic disturbance in the hypothalamus. The clinical and radiologic implications of these findings are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8598994     DOI: 10.1007/bf01403704

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  15 in total

1.  Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance.

Authors:  E Cacciari; S Zucchini; G Carlà; P Pirazzoli; A Cicognani; M Mandini; M Busacca; C Trevisan
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

2.  Growth hormone secretion in Prader-Willi syndrome.

Authors:  H Costeff; V A Holm; R Ruvalcaba; J Shaver
Journal:  Acta Paediatr Scand       Date:  1990-11

3.  Histochemical characterization and functional significance of the hyperintense signal on MR images of the posterior pituitary.

Authors:  J Kucharczyk; W Kucharczyk; I Berry; J de Groot; W Kelly; D Norman; T H Newton
Journal:  AJR Am J Roentgenol       Date:  1989-01       Impact factor: 3.959

4.  The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis.

Authors:  M J Mascari; W Gottlieb; P K Rogan; M G Butler; D A Waller; J A Armour; A J Jeffreys; R L Ladda; R D Nicholls
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

5.  Hyperintense signal of the posterior pituitary on T1-weighted MR images: an experimental study.

Authors:  I Fujisawa; R Asato; M Kawata; Y Sano; K Nakao; T Yamada; H Imura; Y Naito; K Hoshino; S Noma
Journal:  J Comput Assist Tomogr       Date:  1989 May-Jun       Impact factor: 1.826

Review 6.  MR imaging of the brain in patients with diabetes insipidus.

Authors:  R Tien; J Kucharczyk; W Kucharczyk
Journal:  AJNR Am J Neuroradiol       Date:  1991 May-Jun       Impact factor: 3.825

Review 7.  Effects of growth hormone in Prader-Willi syndrome. A case report.

Authors:  R H Ruvalcaba; V A Holm
Journal:  Clin Pediatr (Phila)       Date:  1993-05       Impact factor: 1.168

Review 8.  Prader-Willi syndrome.

Authors:  S B Cassidy
Journal:  Curr Probl Pediatr       Date:  1984-01

9.  Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children.

Authors:  M Argyropoulou; F Perignon; F Brunelle; R Brauner; R Rappaport
Journal:  Pediatr Radiol       Date:  1991

10.  Prader-Willi syndrome: consensus diagnostic criteria.

Authors:  V A Holm; S B Cassidy; M G Butler; J M Hanchett; L R Greenswag; B Y Whitman; F Greenberg
Journal:  Pediatrics       Date:  1993-02       Impact factor: 7.124

View more
  8 in total

Review 1.  Growth hormone therapy in the Prader-Willi syndrome.

Authors:  W F Paterson; M D C Donaldson
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

2.  Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.

Authors:  G Grugni; G Guzzaloni; F Morabito
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

3.  Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice.

Authors:  Alysa A Tennese; Rachel Wevrick
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

Review 4.  Epilepsy in Prader-Willi syndrome: clinical, diagnostic and treatment aspects.

Authors:  Alberto Verrotti; Claudia Soldani; Daniela Laino; Renato d'Alonzo; Salvatore Grosso
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

5.  Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome.

Authors:  L Iughetti; L Bosio; A Corrias; L Gargantini; L Ragusa; C Livieri; B Predieri; P Bruzzi; G Caselli; G Grugni
Journal:  Eur J Pediatr       Date:  2007-09-02       Impact factor: 3.183

6.  Food-related neural circuitry in Prader-Willi syndrome: response to high- versus low-calorie foods.

Authors:  Anastasia Dimitropoulos; Robert T Schultz
Journal:  J Autism Dev Disord       Date:  2008-02-29

Review 7.  Puzzle Pieces: Neural Structure and Function in Prader-Willi Syndrome.

Authors:  Katherine E Manning; Anthony J Holland
Journal:  Diseases       Date:  2015-12-17

8.  Altered functional resting-state hypothalamic connectivity and abnormal pituitary morphology in children with Prader-Willi syndrome.

Authors:  Tonya White; Anita C Hokken-Koelega; Akvile Lukoshe; Suzanne E van Dijk; Gerbrich E van den Bosch; Aad van der Lugt
Journal:  J Neurodev Disord       Date:  2017-02-21       Impact factor: 4.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.